Keywords:
GLP-1 Receptor Agonists; Placebo; Clinical Trials; Obesity
About:
Drawing on findings from the Phase 3 SYNCHRONIZE-1 trial, The “Placebo Hygiene in the GLP-1 Era: When Placebo Participants Find Active Treatment” examines a growing challenge for obesity clinical trials: what happens when participants randomized to placebo discontinue study treatment and gain access to highly effective GLP-1 therapies outside the protocol?”